86 Institutional Investors Started Taking Positions In MetLife, Inc. (MET)

MetLife, Inc. (NYSE:MET) is at least 5.8% than its current record low price of $43.09. There was a -0.28% decline on 43353 that led the price to move at $45.59. At recent session, the prices were hovering between $45.455 and $45.98. This company shares are 16.8% off its target price of $53.25 and the current market capitalization stands at $45.46B. The recent change has given its price a 0.7% lead over SMA 50 and -18.46% deficit over its 52-week high. The stock witnessed -1.15% declines, -4.22% declines and -3.04% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found MET’s volatility during a week at 1.47% and during a month it has been found around 1.56%.

MetLife, Inc. (MET) Top Holders

Institutional investors currently hold around $35.68 billion or 79.2% in MET stock. Look at its top three institutional owners. Blackrock Inc. owns $3.31 billion in MetLife, Inc., which represents roughly 7.27% of the company’s market cap and approximately 9.26% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 68,511,438 shares of the stock are valued at $3.13 billion. The third largest holder is State Street Corp, which currently holds $2.16 billion worth of this stock and that ownership represents nearly 4.76% of its market capitalization.

MetLife, Inc. 13F Filings

At the end of June reporting period, 434 institutional holders increased their position in MetLife, Inc. (NYSE:MET) by some 35,927,961 shares, 521 decreased positions by 48,704,335 and 150 held positions by 695,721,832. That puts total institutional holdings at 780,354,128 shares, according to SEC filings. The stock grabbed 86 new institutional investments totaling 2,651,039 shares while 77 institutional investors sold out their entire positions totaling 4,291,414 shares.

MetLife, Inc. (NYSE:MET) Insider Trades

Multiple company employees have indulged in significant insider trading. MetLife, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chairman, President & CEO Kandarian Steven A has sold 42,805 shares of MetLife, Inc. (MET) in trading session dated Aug. 27, 2018. These shares are worth $2,013,119 and were traded at $47.03 each. The SEC filing shows that Kandarian Steven A performed a sale of 85,683 shares. The Chairman, President & CEO disposed these shares by way of transaction on Aug. 21, 2018. The company’s shares were given away at $46.93 per share worth to an income of some $4,021,103 on account of Kandarian Steven A.

Director, Hassell Gerald L, purchased 10,000 common shares of MetLife, Inc. (MET) in the open market. In a transaction dated May. 09, 2018, the shares were bought at an average price of $46.2, giving away a sum of $461,800. After this purchase, 11,047 common shares of MET are directly owned by the insider, with total stake valued at $503,633.

In the transaction dated Nov. 06, 2017, the great number of shares disposed came courtesy the President, Asia; Townsend Christopher G disposed a total of 55,712 shares at an average price of $54.29, amounting to approximately $3,024,604. The insider now directly owns shares worth $.

MetLife, Inc. (MET) Analyst Guide

Several analysts have released their opinion on MetLife, Inc. (NYSE:MET), with 5 analysts believing it is a strong buy. Whereas 6 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.08 average brokerage recommendation.